Variant:
rs9332239 at chr10:96748777 in CYP2C9

Alleles (on + chromosomal strand)
C > T
Amino Acid Translation
Pro489Ser
Alternate Names:
c.1465C>T, g.47553241C>T, g.55363C>T, p.Pro489Ser
Haplotypes
This variant is used to determine: CYP2C9*12

Clinical Annotations

To see the clinical annotation for this variant please register or sign in.

Variant Annotations

PharmGKB variant annotations provide information about variant-drug pairs based on individual PubMed publications. Each annotation represents information from a single paper and the goal is to report the information that the author states, not an interpretation of the paper. The PMID for supporting PubMed publications is found in the "Evidence" field.

Information presented, including study size, allele frequencies and statistics is taken directly from the publication. However, if the author does not correct p-values in cases of multiple hypotheses, curators may apply a Bonferroni correction. Curators attempt to report study size based on the actual number of participants used for the calculation of the association statistics, so the number may vary slightly from what is reported in the abstract of the paper. OMB Race Category information is derived from the paper and mapped to standardized categories. Category definitions may be found by clicking on the "OMB Race Category" link.

There are 1 annotations for this variant. Register or sign in to see them.

Connected Drugs

Evidence Drug
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
tolbutamide

Publications related to rs9332239 at chr10:96748777: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Discovery of new potentially defective alleles of human CYP2C9. Pharmacogenetics. 2004. Blaisdell Joyce, et al. [Article:15284535@PubMed]

Cross-References

UCSC Golden Path:
chr10:96748777
dbSNP:
rs9332239
HapMap:
rs9332239
LS-SNP:
rs9332239

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.